CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teijin Limited v. Prinston Pharmaceutical Inc.

1:14-cv-00854

Overview

Case Number 1:14-cv-00854
Filing Date 2014-07-01
Status Terminated
Termination Date 2015-11-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Counter Claimant

Prinston Pharmaceutical Inc. Operating Company

Represented By

6 Attorneys Listed

Yongjin Zhu

Email: yongjin.zhu@haynesboone.com

Scott A. Cunning , II

Email: scottcunning@parkerpoe.com

Michael R Ertel

Email: michael.ertel@haynesboone.com

C. Kyle Musgrove

Email: kylemusgrove@parkerpoe.com

Vanessa Ribeiro Tiradentes

Gould & Ratner LLP

Tel: +1 (312) 899-1628

222 N. LaSalle Street, Suite 800

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Counter Defendant

Teijin Pharma Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Teijin Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Takeda Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

Zhiqiang Liu

Email: zliu@pbwt.com

Willam F Cavanaugh , Jr.

Email: wfcavanaugh@pbwt.com

Scott B. Howard

Email: sbhoward@pbwt.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 7 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (7 found):
U.S. Courts: 7
U.S. District Court 2014-11-04
1:14-cv-01370

Teijin Limited v. Unimark Remedies Ltd.

U.S. Family Sibling (["US7361676", "US8372872"])
Status: DED
U.S. District Court 2014-02-12
1:14-cv-00189

Teijin Limited v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-07
1:14-cv-00166

Teijin Limited v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-12-23
1:13-cv-02086

Teijin Limited v. Zydus Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-11-19
1:13-cv-01939

Teijin Limited v. Alembic Pharmaceuticals Limited

Asserted Patent
Status: DED
U.S. District Court 2013-11-06
1:13-cv-01851

Teijin Limited v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-10-30
1:13-cv-01780

Teijin Limited v. Dr. Reddy's Laboratories Ltd.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6225474
Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
Filed: 1999-06-18
Issued: 2001-05-01
Expired (Term Ended)
Expires: 2019-06-18
US8372872
Methods for concomitant treatment of theophylline and febuxostat
Filed: 2011-11-14
Issued: 2013-02-12
Active (5.0 yrs remaining)
Expires: 2031-11-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for defendant to answer, move, or otherwise respond to the First Amended Complaint to December 14, 2015 - filed by Takeda Pharmaceuti...
Entry #38 • 2015-10-29 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME -- Certain Discovery Deadlines -- to Various Dates - see stipulation for details - filed by Takeda Pharmaceuticals USA Inc., Teijin L...
Entry #34 • 2015-09-08 Document →

Docket Entries

(59 total)
Pleading / Complaint

COMPLAINT filed against Prinston Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1545740.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(etg) (Entered: 07/01/2014)

Entry #1 • 2014-07-01
1
Pleading / Complaint

COMPLAINT filed against Prinston Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1545740.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(etg) (Entered: 07/01/2014)

Entry #1 • 2014-07-01
2
Pleading / Complaint

COMPLAINT filed against Prinston Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1545740.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(etg) (Entered: 07/01/2014)

Entry #1 • 2014-07-01
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (etg) (Entered: 07/01/2014)

Entry #2 • 2014-07-01
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/27/2014. Date of Expiration of Patent: 06/18/2019.Thirty Month Stay Deadline: 11/27/2016. (etg) (Entered: 07/01/2014)

Entry #3 • 2014-07-01
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc